Profile data is unavailable for this security.
About the company
HitGen Inc is a China-based company primarily engaged in the research, development and optimization of small molecule and nucleic acid-based new drug candidates using deoxyribonucleic acid (DNA) encoded chemical library (DEL) technology. Through the drug discovery and optimization platform, the Company provides clients with services such as screening and optimization of designated biological targets, customized DEL design and synthesis, synthesis and modification of certain designated compounds or nucleic acids and related biological evaluation. The Company is also engaged in the transfer of rights and interests in new drug research projects, capital operations and marketing activities. The Company primarily operates its businesses in the domestic market and overseas markets, including the United States, France, the United Kingdom and Japan.
- Revenue in CNY (TTM)498.51m
- Net income in CNY114.11m
- Incorporated2012
- Employees483.00
- LocationHitGen IncBlock 6,No.8 Huigu East 1st Road, Tianfu InternaCHENGDU 610200ChinaCHN
- Phone+86 2 885197385
- Fax+86 2 883310298
- Websitehttps://www.hitgen.com/
More ▼
Mergers & acquisitions
| Acquired company | 688222:SHH since announced | Transaction value |
|---|---|---|
| Nanjing Healthnice Pharmaceutical Technology Co Ltd | 90.12% | -- |
Data delayed at least 15 minutes, as of Feb 13 2026.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jiangsu Yahong Meditech Co Ltd | 279.02m | -362.17m | 6.84bn | 391.00 | -- | 3.86 | -- | 24.52 | -0.642 | -0.642 | 0.4933 | 3.10 | 0.125 | 11.16 | 4.19 | 713,603.90 | -16.84 | -14.30 | -19.15 | -15.01 | 72.22 | 73.78 | -134.65 | -703.80 | 4.96 | -- | 0.1545 | -- | 1,365.55 | -- | 4.09 | -- | 50.48 | -- |
| GemPharmatech Co Ltd | 752.70m | 121.51m | 6.98bn | 1.58k | 56.61 | 3.17 | -- | 9.27 | 0.3007 | 0.3007 | 1.86 | 5.37 | 0.2807 | 4.51 | 1.88 | 476,993.40 | 4.53 | 7.69 | 5.42 | 8.96 | 61.84 | 68.17 | 16.14 | 25.58 | 3.17 | -- | 0.1295 | 21.94 | 10.39 | 28.94 | -30.89 | 25.88 | 20.02 | -- |
| Beijing Sun-Novo Pharma Research Co Ltd | 1.02bn | 133.01m | 7.46bn | 1.36k | 54.87 | 6.42 | -- | 7.34 | 1.21 | 1.21 | 9.23 | 10.38 | 0.4745 | 35.48 | 1.28 | 653,956.40 | 6.04 | 11.39 | 10.49 | 18.82 | 48.60 | 53.31 | 12.72 | 19.66 | 1.78 | 9.97 | 0.3355 | 11.29 | 15.70 | 35.80 | -3.98 | 30.21 | 3.50 | -- |
| Shanghai Medicilon Inc | 1.08bn | -231.86m | 8.93bn | 2.27k | -- | 4.33 | -- | 8.27 | -1.75 | -1.75 | 8.04 | 15.36 | 0.3759 | 8.56 | 1.68 | 459,338.00 | -8.08 | 3.66 | -9.99 | 4.63 | 16.27 | 31.15 | -21.49 | 6.67 | 2.19 | -- | 0.1508 | 40.97 | -24.01 | 18.22 | -896.21 | -- | 2.54 | -- |
| Bio-Thera Solutions Ltd | 845.32m | -368.84m | 9.81bn | 1.17k | -- | 20.27 | -- | 11.61 | -0.8908 | -0.8908 | 2.04 | 1.17 | 0.3702 | 0.7722 | 5.96 | -- | -16.15 | -16.38 | -33.76 | -22.22 | 74.99 | 77.05 | -43.63 | -62.11 | 0.4617 | -34.12 | 0.573 | -- | 5.44 | 302.90 | -29.34 | -- | 11.14 | -- |
| HitGen Inc | 498.51m | 114.11m | 11.80bn | 483.00 | 104.30 | 8.02 | -- | 23.67 | 0.2824 | 0.2824 | 1.24 | 3.67 | 0.2726 | 6.37 | 4.69 | 1,032,114.00 | 6.18 | 3.06 | 6.87 | 3.36 | 55.23 | 53.55 | 22.67 | 14.48 | 5.12 | 6.59 | 0.1674 | 34.32 | 14.99 | 10.08 | 26.13 | -15.65 | 3.16 | -- |
| InventisBio Co Ltd | 180.53m | -116.28m | 12.73bn | 185.00 | -- | 7.64 | -- | 70.51 | -0.2012 | -0.2012 | 0.3122 | 2.88 | 0.0988 | -- | 1.03 | 975,824.70 | -6.36 | -32.89 | -6.76 | -35.22 | 99.41 | -- | -64.41 | -682.73 | -- | -- | 0.0127 | -- | -9.02 | 25.00 | 15.41 | -- | -3.97 | -- |
| Mabwell Shanghai Bioscience Co Ltd | 624.52m | -947.49m | 14.55bn | 1.36k | -- | 19.12 | -- | 23.30 | -2.37 | -2.37 | 1.56 | 1.90 | 0.1384 | 0.3458 | 14.57 | 441,048.00 | -21.06 | -29.90 | -36.19 | -36.18 | 88.72 | 85.56 | -152.14 | -1,188.68 | 0.8093 | -10.82 | 0.7353 | -- | 56.28 | 46.68 | 0.9031 | -- | 12.25 | -- |
| Sinocelltech Group Ltd | 1.89bn | -310.15m | 17.54bn | 2.28k | -- | -- | -- | 9.29 | -0.6964 | -0.6964 | 4.24 | -0.1083 | 0.5458 | 0.4325 | 3.04 | 828,989.10 | -8.37 | -22.66 | -29.60 | -48.25 | 93.51 | 95.52 | -15.33 | -42.96 | 0.5008 | -0.6753 | 1.02 | -- | 33.13 | 294.24 | 127.39 | -- | 23.95 | -- |
Data as of Feb 13 2026. Currency figures normalised to HitGen Inc's reporting currency: Chinese Yuan Renminbi CNY
1.11%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 781.59k | 0.20% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 691.90k | 0.17% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 558.78k | 0.14% |
| Broad Fund Management Co. Ltd.as of 30 Jun 2025 | 551.17k | 0.14% |
| CCB Principal Asset Management Co., Ltd.as of 30 Jun 2025 | 471.68k | 0.12% |
| Shanghai Guotai Junan Securities Assets Management Co., Ltd.as of 30 Jun 2025 | 421.25k | 0.11% |
| BlackRock Advisors LLCas of 31 Dec 2025 | 368.51k | 0.09% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2025 | 227.35k | 0.06% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2025 | 196.74k | 0.05% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 186.29k | 0.05% |
More ▼
Data from 30 Jun 2025 - 12 Feb 2026Source: FactSet Research Systems Inc.
